Stephen Carter

Stephen K.
Carter was the founder of Sopherion Therapeutics LLC, founded in 2001, where the title held was Director.
Current jobs include Director at Jazz Pharmaceuticals (EUSA Pharma USA), Inc. since 1998, and Member at both the American Society of Clinical Oncology, Inc. and the Society of Surgical Oncology.
Former jobs include Director at Tamir Biotechnology, Inc. from 1997 to 2010; Director at Emisphere Technologies, Inc. in 2009; Director at Tapestry Pharmaceuticals, Inc. in 2008; Director at Vion Pharmaceuticals, Inc. from 2001 to 2008; Director at Curis, Inc. from 2007 to 2008; Director at Callisto Pharmaceuticals, Inc. from 2004 to 2008; Deputy Director-Cancer Treatment Division at National Cancer Institute from 1967 to 1976; Deputy Director at National Institutes of Health; Director at Celator Pharmaceuticals Corp.; Director at Lixte Biotechnology Holdings, Inc. from 2007 to 2010; SVP-Worldwide Clinical Research & Development at Bristol Myers Squibb Co. from 1982 to 1995; Senior VP-Clinical & Regulatory Affairs at Sugen, Inc. in 2000; Senior Vice President-Research & Development at Boehringer Ingelheim Pharmaceuticals, Inc. from 1995 to 1997; and Member at American Association for Cancer Research.
Education includes undergraduate degree from The Trustees of Columbia University in The City of New York and doctorate from New York Medical College.